Growth pattern switch of renal cells and expression of cell cycle related proteins at the early stage of diabetic nephropathy

Biochemical and Biophysical Research Communications

Volumn 363, Issue 1, 2007, Pages 159-164

  Zhang, Yanling ^a   Shi, Yonghong ^a   Liu, Yaling ^a   Dong, Hui ^a   Liu, Maodong ^a   Li, Ying ^a   Duan, Huijun ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

CDK2; Cyclin E; Diabetic nephropathy; Hypertrophy; P27; Proliferation

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN E; PROTEIN P27; STREPTOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; GENE ACTIVITY; GENE EXPRESSION; GENETIC SCREENING; KIDNEY CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION;

ANIMALS; CELL CYCLE PROTEINS; CELLS, CULTURED; DIABETIC NEPHROPATHIES; GENE EXPRESSION REGULATION, DEVELOPMENTAL; KIDNEY; MALE; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 34548722650     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.08.139     Document Type: Article

References (25)

1. Baumgartl H.J., Sigl G., Banholzer P., Haslbeck M., and Standl E. On the prognosis of IDDM patients with large kidneys. Nephrol Dial Transplant 13 (1998) 630-634
2. Osterby R., and Gundersen H.J. Fast accumulation of basement membrane material and the rate of morphological changes in acute experimental diabetic glomerular hypertrophy. Diabetologia 18 (1980) 493-500
3. Rabkin R., and Fervenza F.C. Renal hypertrophy and kidney disease in diabetes. Diabetes Metab. Rev. 12 (1996) 217-241
4. Kennefick T.M., and Anderson S. Role of angiotensin II in diabetic nephropathy. Semin. Nephrol. 17 (1997) 441-447
5. Rasch R., and Norgaard J.O. Renal enlargement: comparative autoradiographic studies of 3H-thymidine uptake in diabetic and uninephrectomized rats. Diabetologia 25 (1983) 280-287
6. Shankland S.J. Cell-cycle control and renal disease. Kidney Int. 52 (1997) 294-308
7. Hunt T. Cyclins and their partners: from a simple idea to complicated reality. Semin. Cell Biol. 2 (1991) 213-222
8. Sherr C.J., and Roberts J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9 (1995) 1149-1163
9. Luo Y., Hurwitz J., and Massague J. Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1. Nature 375 (1995) 159-161
10. Toyoshima H., and Hunter T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78 (1994) 67-74
11. Lee M.H., Reynisdottir I., and Massague J. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. 9 (1995) 639-649
12. Preisig P.A., and Franch H.A. Renal epithelial cell hyperplasia and hypertrophy. Semin. Nephrol. 15 (1995) 327-340
13. Zhang X., Chen X., Wu D., Liu W., Wang J., Feng Z., Cai G., Fu B., Hong Q., and Du J. Downregulation of connexin 43 expression by high glucose induces senescence in glomerular mesangial cells. J. Am. Soc. Nephrol. 17 (2006) 1532-1542
14. Eguchi J., Wada J., Hida K., Zhang H., Matsuoka T., Baba M., Hashimoto I., Shikata K., Ogawa N., and Makino H. Identification of adipocyte adhesion molecule (ACAM), a novel CTX gene family, implicated in adipocyte maturation and development of obesity. Biochem. J. 387 (2005) 343-353
15. Wolf G., and Ziyadeh F.N. Molecular mechanisms of diabetic renal hypertrophy. Kidney Int. 56 (1999) 393-405
16. MacLeod J.M., White K.E., Tate H., and Bilous R.W. Efficient morphometric analysis of glomerular mesangium in insulin-dependent diabetic patients with early nephropathy. The European study of the progression of renal disease in type 1 (insulin dependent) diabetes (ESPRIT) study group. Kidney Int. 51 (1997) 1624-1628
17. Osterby R. Glomerular structural changes in type 1 (insulin-dependent) diabetes mellitus: causes, consequences, and prevention. Diabetologia 35 (1992) 803-812
18. Palm F., Ortsater H., Hansell P., Liss P., and Carlsson P.O. Differentiating between effects of streptozotocin per se and subsequent hyperglycemia on renal function and metabolism in the streptozotocin-diabetic rat model. Diabetes Metab. Res. Rev. 20 (2004) 452-459
19. Young B.A., Johnson R.J., Alpers C.E., Eng E., Gordon K., Floege J., Couser W.G., and Seidel K. Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int. 47 (1995) 935-944
20. Kuan C.J., al-Douahji M., and Shankland S.J. The cyclin kinase inhibitor p21WAF1, CIP1 is increased in experimental diabetic nephropathy: potential role in glomerular hypertrophy. J. Am. Soc. Nephrol. 9 (1998) 986-993
21. McCormick D., and Hall P.A. The complexities of proliferating cell nuclear antigen. Histopathology 21 (1992) 591-594
22. Gratzner H.G. Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication. Science 218 (1982) 474-475
23. Preisig P. A cell cycle-dependent mechanism of renal tubule epithelial cell hypertrophy. Kidney Int. 56 (1999) 1193-1198
24. Megyesi J., Price P.M., Tamayo E., and Safirstein R.L. The lack of a functional p21(WAF1/CIP1) gene ameliorates progression to chronic renal failure. Proc. Natl. Acad. Sci. USA 96 (1999) 10830-10835
25. Al-Awqati Q., and Preisig P.A. Size does matter: will knockout of p21 (WAF1/CIP1) save the kidney by limiting compensatory renal growth?. Proc. Natl. Acad. Sci. USA 96 (1999) 10551-10553